64464-07-9Carvedilol EP Impurity E (HCl Salt)
● En Stock
| Número de catálogo: | VL35001 |
|---|---|
| N.º CAS: | 64464-07-9 |
| Fórmula mol.:: | C9H14ClNO2 |
| Peso mol.:: | 203.67 g/mol |
Información adicional sobre el CAS 64464-07-9
Fármaco de origen
CarvedilolNombre IUPAC
2-(2-methoxyphenoxy) ethanamine HClSinónimos farmacopeicos
Carvedilol Related Compound E (HCl Salt)Otros sinónimos
Carvedilol Impurity 1; 2-(2-Methoxyphenoxy)ethylamine Hydrochloride; 2-(2-methoxyphenoxy)ethan-1-amine hydrochloride; 1-(2-Aminoethoxy)-2-methoxybenzene Hydrochloride; 1-(2-Aminoethoxy)-2-methoxybenzene Hydrochloride; 2-(2-Aminoethoxy)anisole HydrochlorideSMILES
COC1=CC=CC=C1OCCN.[H]ClInChI
InChI=1S/C9H13NO2.ClH/c1-11-8-4-2-3-5-9(8)12-7-6-10;/h2-5H,6-7,10H2,1H3;1HCondición de envío
Ambient TemperatureCharacterization Data (Included)
HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).Datos adicionales de caracterización
QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.Descripción
Carvedilol EP Impurity E (HCl Salt) known in pharmacopoeias as Carvedilol Related Compound E (HCl Salt) is a thoroughly characterized reference standard. It meets strict regulatory standards including those set by USP EMA JP and BP. This product is crucial for use in Abbreviated New Drug Applications (ANDA) New Drug Applications (NDA) and the commercial production of Carvedilol. Additionally it comes with a detailed Structure Elucidation Report (SER) ensuring its precision and dependability for a variety of analytical uses.
Solicitar cotización
"*" señala los campos obligatorios









